Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury
International Journal of Molecular Sciences · 23.03.2023 · 24 (7) · 6086
DOI: 10.3390/ijms24076086 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.03.2023. Verfasst von Qingyu Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Taneja College of Pharmacy, University of South Florida, Tampa, FL 33620, USA. Hauptthemen laut MEDLINE: Fluorocarbons, Acute Kidney Injury, Nanoparticles. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIH.
Abstract (Originalsprache)
For nearly five decades, cisplatin has played an important role as a standard chemotherapeutic agent and been prescribed to 10–20% of all cancer patients. Although nephrotoxicity associated with platinum-based agents is well recognized, treatment of cisplatin-induced acute kidney injury is mainly supportive and no specific mechanism-based prophylactic approach is available to date. Here, we postulated that systemically delivered rapamycin perfluorocarbon nanoparticles (PFC NP) could reach the injured kidneys at sufficient and sustained concentrations to mitigate cisplatin-induced acute kidney injury and preserve renal function. Using fluorescence microscopic imaging and fluorine magnetic resonance imaging/spectroscopy, we illustrated that rapamycin-loaded PFC NP permeated and were retained in injured kidneys. Histologic evaluation and blood urea nitrogen (BUN) confirmed that renal structure and function were preserved 48 h after cisplatin injury. Similarly, weight loss was slowed down. Using western blotting and immunofluorescence staining, mechanistic studies revealed that rapamycin PFC NP significantly enhanced autophagy in the kidney, reduced the expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1), as well as decreased the expression of the apoptotic protein Bax, all of which contributed to the suppression of apoptosis that was confirmed with TUNEL staining. In summary, the delivery of an approved agent such as rapamycin in a PFC NP format enhances local delivery and offers a novel mechanism-based prophylactic therapy for cisplatin-induced acute kidney injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Taneja College of Pharmacy, University of South Florida, Tampa, FL 33620, USA.
- Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Division of Rheumatology, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Morsani College of Medicine, University of South Florida, Tampa, FL 33620, USA.
ORCID-Profile: Christine T N Pham
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NIH
Zitieren
APA
Zhou, Q., Quirk, J. D., Hu, Y., Yan, H., Gaut, J. P., Pham, C. T. N., Wickline, S. A., & Pan, H. (2023). Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury. International Journal of Molecular Sciences, 24(7), 6086. https://doi.org/10.3390/ijms24076086
Vancouver
Zhou Q, Quirk JD, Hu Y, Yan H, Gaut JP, Pham CTN, et al. Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury. International Journal of Molecular Sciences. 2023;24(7):6086. doi:10.3390/ijms24076086
BibTeX
@article{Zhou2023,
author = {Zhou, Qingyu and Quirk, James D and Hu, Ying and Yan, Huimin and Gaut, Joseph P and Pham, Christine T N and Wickline, Samuel A and Pan, Hua},
title = {Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {7},
pages = {6086},
doi = {10.3390/ijms24076086}
}
EUVIMED